Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Sold by Laird Norton Wetherby Wealth Management LLC

Laird Norton Wetherby Wealth Management LLC reduced its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 21.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 20,360 shares of the pharmacy operator’s stock after selling 5,426 shares during the period. Laird Norton Wetherby Wealth Management LLC’s holdings in Walgreens Boots Alliance were worth $190,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently made changes to their positions in the stock. Integral Health Asset Management LLC bought a new stake in shares of Walgreens Boots Alliance in the 4th quarter worth approximately $4,665,000. Janus Henderson Group PLC raised its holdings in shares of Walgreens Boots Alliance by 1.9% in the 4th quarter. Janus Henderson Group PLC now owns 89,601 shares of the pharmacy operator’s stock worth $836,000 after purchasing an additional 1,644 shares in the last quarter. Humankind Investments LLC raised its holdings in shares of Walgreens Boots Alliance by 34.6% in the 4th quarter. Humankind Investments LLC now owns 48,650 shares of the pharmacy operator’s stock worth $454,000 after purchasing an additional 12,493 shares in the last quarter. Gotham Asset Management LLC raised its holdings in shares of Walgreens Boots Alliance by 12.6% in the 4th quarter. Gotham Asset Management LLC now owns 472,756 shares of the pharmacy operator’s stock worth $4,411,000 after purchasing an additional 52,754 shares in the last quarter. Finally, Ensign Peak Advisors Inc raised its holdings in shares of Walgreens Boots Alliance by 7.9% in the 4th quarter. Ensign Peak Advisors Inc now owns 334,030 shares of the pharmacy operator’s stock worth $3,116,000 after purchasing an additional 24,427 shares in the last quarter. 58.59% of the stock is owned by institutional investors and hedge funds.

Walgreens Boots Alliance Stock Up 1.0%

Walgreens Boots Alliance stock opened at $11.29 on Friday. The firm has a market cap of $9.76 billion, a PE ratio of -1.10, a P/E/G ratio of 1.31 and a beta of 0.77. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64. The firm’s 50 day moving average price is $11.02 and its two-hundred day moving average price is $10.36. Walgreens Boots Alliance, Inc. has a twelve month low of $8.08 and a twelve month high of $18.17.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Tuesday, April 8th. The pharmacy operator reported $0.63 earnings per share for the quarter, beating the consensus estimate of $0.53 by $0.10. The firm had revenue of $38.59 billion for the quarter, compared to analyst estimates of $37.90 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The company’s revenue for the quarter was up 4.1% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.20 EPS. On average, research analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of analysts recently commented on WBA shares. Wolfe Research upgraded shares of Walgreens Boots Alliance to a “hold” rating in a report on Monday, February 24th. StockNews.com initiated coverage on shares of Walgreens Boots Alliance in a report on Tuesday, May 13th. They set a “hold” rating on the stock. Deutsche Bank Aktiengesellschaft lowered shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating and cut their price target for the company from $11.00 to $9.00 in a report on Friday, February 28th. Finally, Truist Financial cut their price target on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a report on Friday, January 31st. Four analysts have rated the stock with a sell rating, seven have issued a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $10.59.

Insiders Place Their Bets

In other Walgreens Boots Alliance news, Chairman Stefano Pessina bought 832,258 shares of the firm’s stock in a transaction on Sunday, April 27th. The stock was bought at an average cost of $11.01 per share, with a total value of $9,163,160.58. Following the completion of the transaction, the chairman now directly owns 145,621,079 shares of the company’s stock, valued at approximately $1,603,288,079.79. The trade was a 0.57% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 17.50% of the company’s stock.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.